EXCLUSIVE: Avalon GloboCare Tells Benzinga Co. And Qi Diagnostics Enter Into Memorandum Of Understanding For Proposed Co-Development Of Real-Time Cannabis Breathalyzer For Detecting Potential Impaired Driving
Portfolio Pulse from Benzinga Newsdesk
Avalon GloboCare and Qi Diagnostics have entered into a Memorandum of Understanding to co-develop a real-time cannabis breathalyzer aimed at detecting potential impaired driving.
October 25, 2024 | 12:29 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Avalon GloboCare has partnered with Qi Diagnostics to develop a cannabis breathalyzer, which could position the company as a leader in cannabis impairment detection technology.
The partnership with Qi Diagnostics to develop a cannabis breathalyzer is a strategic move for Avalon GloboCare, potentially opening new markets and increasing its technological footprint. This could lead to positive investor sentiment and a short-term stock price increase.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 90